PTEN and hepatocellular carcinoma: Untargeted metabolomics of liver tissues from a genetically engineered mouse model of HCC, driven by liver-specific knockout of tuberous sclerosis complex 1 (TSC1) and phosphatase and tensin homolog (PTEN), revealed broad metabolic alterations in liver tumours compared to controls.